Postnatal glycaemic outcomes in women with high-risk gestational diabetes: Identifying key predictors for early intervention.

IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Diabetes, Obesity & Metabolism Pub Date : 2025-02-01 Epub Date: 2024-11-27 DOI:10.1111/dom.16085
Pei Chia Eng, Soo Hoon Lee, Ada Ee Der Teo, Dawn Se Teng Lim, Lyeann Li Ying Tan, Guat Kian Tan, E Shyong Tai, Phillip Phan, Chin Meng Khoo
{"title":"Postnatal glycaemic outcomes in women with high-risk gestational diabetes: Identifying key predictors for early intervention.","authors":"Pei Chia Eng, Soo Hoon Lee, Ada Ee Der Teo, Dawn Se Teng Lim, Lyeann Li Ying Tan, Guat Kian Tan, E Shyong Tai, Phillip Phan, Chin Meng Khoo","doi":"10.1111/dom.16085","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Women with gestational diabetes (GDM) have increased lifetime risk of developing diabetes. We aim to determine the factors contributing to poor adherence of the postpartum oral glucose tolerance test (OGTT) and identify key predictors to postpartum dysglycaemia in our Asian cohort.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of women with high-risk GDM (n = 561). High-risk women with GDM were defined as (1) women with diabetic-range glucose excursions on an antepartum OGTT, (2) women diagnosed GDM on early OGTT and (3) women requiring ≥20 units of insulin during antepartum period. We use logistic regression predictive models to associate maternal variables with postpartum OGTT attendance and glucose tolerance status postnatally.</p><p><strong>Results: </strong>Between March 2020 to March 2024, 58.7% (n = 329) of women returned for postpartum OGTT. Predictors for attendance of postpartum OGTT were Chinese ethnicity (odds ratio [OR] 2.11, 95% confidence interval [CI] [1.14-3.89]), pre-pregnancy body mass index (BMI) (OR 0.95 [95% CI 0.90-0.99]), first GDM (OR 2.34 [95% CI 1.39-3.96]) and 2-h glucose threshold on antepartum OGTT (OR 0.87 [95% CI 0.76-0.99]). Ethnicity influences postnatal dysglycaemia outcomes in our cohort. Chinese women, compared to women of Malay ethnicity, had a 4.5-odds of persistent postpartum dysglycaemia. An antenatal HbA1c of ≥5.7% and an elevated 2-h post-OGTT glucose value significantly predict postpartum dysglycaemia independent of ethnicity.</p><p><strong>Conclusion: </strong>Ethnicity-specific prediction models integrating antepartum OGTT and HbA1c predict postpartum dysglycaemia in a multiethnic Southeast Asian cohort. Using these predictive models, we could identify high-risk patients for early intervention.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"845-855"},"PeriodicalIF":5.4000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.16085","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Women with gestational diabetes (GDM) have increased lifetime risk of developing diabetes. We aim to determine the factors contributing to poor adherence of the postpartum oral glucose tolerance test (OGTT) and identify key predictors to postpartum dysglycaemia in our Asian cohort.

Methods: We conducted a retrospective cohort study of women with high-risk GDM (n = 561). High-risk women with GDM were defined as (1) women with diabetic-range glucose excursions on an antepartum OGTT, (2) women diagnosed GDM on early OGTT and (3) women requiring ≥20 units of insulin during antepartum period. We use logistic regression predictive models to associate maternal variables with postpartum OGTT attendance and glucose tolerance status postnatally.

Results: Between March 2020 to March 2024, 58.7% (n = 329) of women returned for postpartum OGTT. Predictors for attendance of postpartum OGTT were Chinese ethnicity (odds ratio [OR] 2.11, 95% confidence interval [CI] [1.14-3.89]), pre-pregnancy body mass index (BMI) (OR 0.95 [95% CI 0.90-0.99]), first GDM (OR 2.34 [95% CI 1.39-3.96]) and 2-h glucose threshold on antepartum OGTT (OR 0.87 [95% CI 0.76-0.99]). Ethnicity influences postnatal dysglycaemia outcomes in our cohort. Chinese women, compared to women of Malay ethnicity, had a 4.5-odds of persistent postpartum dysglycaemia. An antenatal HbA1c of ≥5.7% and an elevated 2-h post-OGTT glucose value significantly predict postpartum dysglycaemia independent of ethnicity.

Conclusion: Ethnicity-specific prediction models integrating antepartum OGTT and HbA1c predict postpartum dysglycaemia in a multiethnic Southeast Asian cohort. Using these predictive models, we could identify high-risk patients for early intervention.

高危妊娠糖尿病妇女的产后血糖结果:确定早期干预的关键预测因素。
目的:患有妊娠糖尿病(GDM)的妇女终生罹患糖尿病的风险增加。我们旨在确定导致产后口服葡萄糖耐量试验(OGTT)依从性差的因素,并找出亚洲队列中产后血糖异常的主要预测因素:我们对高危 GDM 妇女(n = 561)进行了一项回顾性队列研究。高危 GDM 妇女的定义是:(1)产前 OGTT 血糖偏离糖尿病范围的妇女;(2)早期 OGTT 诊断为 GDM 的妇女;(3)产前需要胰岛素≥20 单位的妇女。我们使用逻辑回归预测模型将产妇变量与产后参加 OGTT 和产后糖耐量状况联系起来:结果:2020 年 3 月至 2024 年 3 月期间,58.7%(n = 329)的产妇返回进行产后 OGTT。参加产后 OGTT 的预测因素包括华裔(几率比 [OR] 2.11,95% 置信区间 [CI] [1.14-3.89])、孕前体重指数(BMI)(OR 0.95 [95% CI 0.90-0.99])、首次 GDM(OR 2.34 [95% CI 1.39-3.96])和产前 OGTT 的 2 小时葡萄糖阈值(OR 0.87 [95% CI 0.76-0.99])。在我们的队列中,种族对产后血糖异常的结果有影响。与马来族妇女相比,华裔妇女产后持续血糖异常的几率为 4.5。产前 HbA1c≥5.7% 和 2 hOGTT 后血糖值升高可显著预测产后血糖异常,与种族无关:结论:结合产前 OGTT 和 HbA1c 的特定种族预测模型可预测东南亚多种族队列中的产后血糖异常。利用这些预测模型,我们可以识别出需要早期干预的高危患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信